Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Neurogene Inc. | 350,000 | reported | 02 Aug 2022 | tx 23+5,723,158−162,616 |
| Calithera Biosciences, Inc. | 200,000 | reported | 10 Nov 2021 | tx 8+295,000 |
| SEATTLE GENETICS INC /WA | 45,000 | reported | 20 Mar 2018 | tx 65+483,354−204,772 |
| Harpoon Therapeutics, Inc. | 0 | reported | 11 Mar 2024 | tx 14+86,396−14,262 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 5,415 | — | |
| 08 Mar 2024 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 415 | 0.00 USD | |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 1,016 | — | deriv |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 2,300 | — | deriv |
| 11 Mar 2024 | OTHER | Harpoon Therapeutics, Inc. | 5,531 | — | deriv |
| 27 Nov 2023 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 5,000 | 0.00 USD | |
| 22 Jun 2023 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 23,000 | 0.00 USD | deriv |
| 02 Aug 2022 | GRANT_AWARD | Neurogene Inc. | 350,000 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 10,167 | 0.00 USD | deriv |
| 26 Oct 2021 | GIFT | Neurogene Inc. | 75,000 | 0.00 USD | |
| 26 Oct 2021 | GIFT | Neurogene Inc. | 75,000 | 0.00 USD | |
| 26 Oct 2021 | GIFT | Neurogene Inc. | 75,000 | 0.00 USD | |
| 26 Oct 2021 | GIFT | Neurogene Inc. | 75,000 | 0.00 USD | |
| 10 Nov 2021 | PURCHASE | Calithera Biosciences, Inc. | 200,000 | 0.86 USD | |
| 25 Aug 2021 | PURCHASE | Neurogene Inc. | 25,000 | 6.45 USD | |
| 24 Aug 2021 | PURCHASE | Neurogene Inc. | 100,000 | 6.11 USD | |
| 25 Aug 2021 | PURCHASE | Neurogene Inc. | 25,000 | 6.45 USD | |
| 03 Aug 2021 | GRANT_AWARD | Neurogene Inc. | 400,000 | 0.00 USD | deriv |
| 11 Jun 2021 | GRANT_AWARD | Calithera Biosciences, Inc. | 20,000 | 0.00 USD | deriv |
| 04 Jun 2021 | PURCHASE | Neurogene Inc. | 10,000 | 9.61 USD | |
| 03 Jun 2021 | PURCHASE | Neurogene Inc. | 40,000 | 9.48 USD | first after silence |
| 04 May 2021 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 10,167 | 0.00 USD | deriv |
| 10 Aug 2020 | GRANT_AWARD | Neurogene Inc. | 420,000 | 0.00 USD | deriv |
| 09 Jun 2020 | GRANT_AWARD | Calithera Biosciences, Inc. | 20,000 | 0.00 USD | deriv |
| 28 May 2020 | GRANT_AWARD | Harpoon Therapeutics, Inc. | 2,880 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 03 Jun 2021.